SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-012150
Filing Date
2019-04-22
Accepted
2019-04-19 21:31:19
Documents
7
Period of Report
2019-06-13
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 PTLA-2019PROXY-DEF 14A ptla-def14a_20190613.htm DEF 14A 2319463
2 GRAPHIC gcudixk42iwy000001.jpg GRAPHIC 5840
3 GRAPHIC gcudixk42iwy000003.jpg GRAPHIC 4470
4 GRAPHIC gcudixk42iwy000006.jpg GRAPHIC 39726
5 GRAPHIC gcudixk42iwy000004.jpg GRAPHIC 1273
6 GRAPHIC gcudixk42iwy000002.jpg GRAPHIC 1273
7 GRAPHIC gcudixk42iwy000005.jpg GRAPHIC 97269
  Complete submission text file 0001564590-19-012150.txt   2527826
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35935 | Film No.: 19758438
SIC: 2834 Pharmaceutical Preparations